Clinical trial
A Multicenter Randomized Controlled Trial for Comparing Endonasal Surgery and Radiation Therapy (IMRT) for T1-T2 Recurrent Nasopharyngeal Carcinoma
NCT04215510 is registered in ClinicalTrials.gov with Eye & ENT Hospital of Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Randomized Controlled Trial for Comparing Endonasal Surgery and Radiation Therapy (IMRT) for T1-T2 Recurrent Nasopharyngeal Carcinoma
- Lead sponsor
- Eye & ENT Hospital of Fudan University
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- March 1, 2021
- Completion date
- March 1, 2027
- Enrollment
- 286 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent nasopharyngeal carcinoma